Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Newellis (NUWE)

Newellis Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NUWE
DateTimeSourceHeadlineSymbolCompany
19/10/202212:00GlobeNewswire Inc.Nuwellis Announces Appointment of Chief Financial OfficerNASDAQ:NUWENewellis Inc
18/10/202221:15GlobeNewswire Inc.Nuwellis Announces Closing of $11.04 Million Underwritten Public Offering Including Full Exercise of Overallotment OptionNASDAQ:NUWENewellis Inc
17/10/202221:08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:NUWENewellis Inc
17/10/202211:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:NUWENewellis Inc
14/10/202213:30GlobeNewswire Inc.Nuwellis Announces Pricing of $9.6 Million Upsized Underwritten Public OfferingNASDAQ:NUWENewellis Inc
14/10/202211:08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NUWENewellis Inc
13/10/202222:01Edgar (US Regulatory)Registration of Additional Securities (up to 20%) (s-1mef)NASDAQ:NUWENewellis Inc
13/10/202211:04Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:NUWENewellis Inc
12/10/202213:41Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:NUWENewellis Inc
06/10/202222:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NUWENewellis Inc
06/10/202222:27Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:NUWENewellis Inc
03/10/202213:57Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:NUWENewellis Inc
03/10/202213:48Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NUWENewellis Inc
03/10/202212:00GlobeNewswire Inc.Nuwellis Announces Data Demonstrating Statistically Superior Clinical Benefit of Aquadex Therapy in Reducing Heart Failure Events and Mortality at the 2022 HFSA MeetingNASDAQ:NUWENewellis Inc
30/09/202211:06Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:NUWENewellis Inc
27/09/202214:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NUWENewellis Inc
27/09/202212:00GlobeNewswire Inc.Nuwellis Announces the Activation of New Sites for Its Pivotal REVERSE-HF TrialNASDAQ:NUWENewellis Inc
23/09/202221:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NUWENewellis Inc
09/09/202222:17Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:NUWENewellis Inc
31/08/202212:00GlobeNewswire Inc.Nuwellis Announces New Clinical Data Demonstrating 100% Survival at 30 Days Following Use of Ultrafiltration in High-Risk Postoperative Coronary Artery Bypass Grafting (CABG) PatientsNASDAQ:NUWENewellis Inc
25/08/202212:00GlobeNewswire Inc.U.S. Patent and Trademark Office Awards Nuwellis Patent for Innovative Pediatric TechnologyNASDAQ:NUWENewellis Inc
19/08/202220:00GlobeNewswire Inc.Nuwellis, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:NUWENewellis Inc
19/08/202213:00GlobeNewswire Inc.Nuwellis Inc. to Present at the Inaugural Gilmartin Group Emerging Growth Company ShowcaseNASDAQ:NUWENewellis Inc
10/08/202220:25TipRanksMaxim Group Reaffirms Their Buy Rating on Nuwellis (NUWE)NASDAQ:NUWENewellis Inc
09/08/202213:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NUWENewellis Inc
09/08/202213:00GlobeNewswire Inc.Nuwellis, Inc. Announces Second Quarter 2022 Financial ResultsNASDAQ:NUWENewellis Inc
26/07/202212:00GlobeNewswire Inc.Nuwellis Announces the Submission of the AVOID-HF Clinical Analysis as a Late Breaking Clinical Trial at HFSANASDAQ:NUWENewellis Inc
14/07/202213:00GlobeNewswire Inc.Nuwellis, Inc. To Announce Second Quarter 2022 Financial Results on August 9, 2022NASDAQ:NUWENewellis Inc
12/07/202212:00GlobeNewswire Inc.Nuwellis Initiates Its Outpatient Heart Failure Strategy Using Aquadex Ultrafiltration TherapyNASDAQ:NUWENewellis Inc
29/06/202212:00GlobeNewswire Inc.Nuwellis Announces First Patient Enrolled in its Pivotal Trial REVERSE-HFNASDAQ:NUWENewellis Inc
 Showing the most relevant articles for your search:NASDAQ:NUWE